Net Loss of Lasa Supergenerics reported to Rs 14.29 crore in the quarter ended March 2025 as against net loss of Rs 15.30 crore during the previous quarter ended March 2024. Sales rose 71.52% to Rs 39.14 crore in the quarter ended March 2025 as against Rs 22.82 crore during the previous quarter ended March 2024.
For the full year,net loss reported to Rs 14.76 crore in the year ended March 2025 as against net loss of Rs 21.73 crore during the previous year ended March 2024. Sales rose 36.52% to Rs 142.45 crore in the year ended March 2025 as against Rs 104.34 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 39.14 | 22.82 | 72 | 142.45 | 104.34 | 37 |
| OPM % | 8.71 | -17.48 | - | 4.39 | 2.07 | - |
| PBDT | 5.69 | -4.54 | LP | 8.58 | 0.33 | 2500 |
| PBT | 1.79 | -7.20 | LP | -3.72 | -10.34 | 64 |
| NP | -14.29 | -15.30 | 7 | -14.76 | -21.73 | 32 |